- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
| home:patients:grappling_uncertainty [06.06.2019] – [Confronting uncertainty about the Marshall Protocol] sallieq | home:patients:grappling_uncertainty [06.06.2019] – [One pathology, one treatment] sallieq | ||
|---|---|---|---|
| Line 13: | Line 13: | ||
| * if patients take a therapy which makes them feel better in the short-term, that means they are getting healthier in the long-term | * if patients take a therapy which makes them feel better in the short-term, that means they are getting healthier in the long-term | ||
| * diseases caused by bacteria are caused by a single species | * diseases caused by bacteria are caused by a single species | ||
| - | * bacteria are mostly beneficial | + | |
| The MP study site does not have the resources to support amateur scientists who offer up theories that build upon the work of the Autoimmunity Research Foundation (ARF), nor it does have the resources to explain how a study reconciles with the latest ARF research. | The MP study site does not have the resources to support amateur scientists who offer up theories that build upon the work of the Autoimmunity Research Foundation (ARF), nor it does have the resources to explain how a study reconciles with the latest ARF research. | ||
| Line 21: | Line 21: | ||
| ===== One pathology, one treatment ===== | ===== One pathology, one treatment ===== | ||
| - | People also seem to have trouble grappling with root causes. They may point to a sign or symptom of disease: low blood pressure, elevated cholesterol, | + | People also seem to have trouble grappling with root causes. They may point to a sign or symptom of disease: low blood pressure, elevated cholesterol, anemia, trouble sleeping, low levels of a hormone, etc., and conclude that a certain factor causes the disease. The problem with this line of thinking is that the disease does not go away when that factor is remedied--when medications are used to increase cholesterol or medications are used to decrease blood pressure. On the other hand, patients who take regular frequent doses of olmesartan (Benicar) and in some cases, pulsed low doses of antibiotics do see improvement in their underlying disease. |
| ===== Evaluating the Marshall Protocol ===== | ===== Evaluating the Marshall Protocol ===== | ||
home/patients/grappling_uncertainty.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.